 - Patients with impaired bone marrow reserve, as indicated by one or more of the following: Prior myeloablative therapies with allogeneic or autologous bone marrow transplantation ABMT or peripheral blood stem cell PBSC rescue; Platelet count 100,000 cellsmm3; Prior external beam radiation to 25 of active bone marrow; History of failed stem cell collection 